Can-Fite BioPharma (CANF) Net Income Attributable to Noncontrolling Interests (2012 - 2017)
Can-Fite BioPharma (CANF) recorded Net Income Attributable to Noncontrolling Interests of -$6.57 million in FY2018, compared with -$94,000 in FY2017.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Net Income Attributable to Noncontrolling Interests (2012 - 2017) Analysis & Trends
Starting with FY2011, Can-Fite BioPharma's Net Income Attributable to Noncontrolling Interests history includes 8 years.
- The FY2018 figure is the lowest annual Net Income Attributable to Noncontrolling Interests in data going back to FY2011.
- Per Business Quant data, CANF's Net Income Attributable to Noncontrolling Interests was -$94,000 in FY2017, $136,000 in FY2016 (-48.9%), $266,000 in FY2015 (+23.9%) and $214,619 in FY2014 (-56.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Can-Fite BioPharma | 2.16 Mn | -17.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -176,000.00 |
| Sep 30, 2017 | 29,000.00 |
| Jun 30, 2017 | 74,000.00 |
| Mar 31, 2017 | -21,000.00 |
| Dec 31, 2016 | 66,000.00 |
| Sep 30, 2016 | 27,000.00 |
| Jun 30, 2016 | 39,000.00 |
| Mar 31, 2016 | 4,000.00 |
| Dec 31, 2015 | 109,000.00 |
| Sep 30, 2015 | 63,834.45 |
| Jun 30, 2015 | 57,879.46 |
| Mar 31, 2015 | 37,000.00 |
| Dec 31, 2014 | 63,915.77 |
| Sep 30, 2014 | 51,033.98 |
| Jun 30, 2014 | 31,786.82 |
| Mar 31, 2014 | 67,000.00 |
| Dec 31, 2013 | 55,404.99 |
| Sep 30, 2013 | 113,496.02 |
| Jun 30, 2013 | 189,073.35 |
| Mar 31, 2013 | 128,867.88 |
API Access
Can-Fite BioPharma Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();